Intercept Pharmaceuticals... (ICPT)
NASDAQ: ICPT
· Real-Time Price · USD
19.00
0.04 (0.21%)
At close: Nov 07, 2023, 10:00 PM
Intercept Pharmaceuticals Revenue
Intercept Pharmaceuticals reported an annual revenue of $285.71M, reflecting a -21.39% growth. For the quarter ending September 30, 2023, Intercept Pharmaceuticals generated $88.79M in revenue.
Revenue (ttm)
285.71M
Revenue Growth
-21.39%
Price / Sales Ratio
1.46
Revenue / Employee
837.86K
Employees
341
Market Cap
794.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2022 | 285.71M | -21.39% |
| Dec 31, 2021 | 363.47M | +16.24% |
| Dec 31, 2020 | 312.69M | +24.08% |
| Dec 31, 2019 | 252M | +40.15% |
| Dec 31, 2018 | 179.8M | +37.30% |
| Dec 31, 2017 | 130.96M | +424.85% |
| Dec 31, 2016 | 24.95M | +796.87% |
| Dec 31, 2015 | 2.78M | +59.70% |
| Dec 31, 2014 | 1.74M | +7.42% |
| Dec 31, 2013 | 1.62M | -33.70% |
| Dec 31, 2012 | 2.45M | +35.50% |
| Dec 31, 2011 | 1.81M | +Infinity% |
| Dec 31, 2010 | 0 | n/a |